Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096195771> ?p ?o ?g. }
- W3096195771 endingPage "e317" @default.
- W3096195771 startingPage "e309" @default.
- W3096195771 abstract "The cumulative incidence, risk factors, rate of subsequent venous thromboembolism (VTE) and bleeding and impact on mortality of isolated upper extremity deep vein thrombosis (UE DVT) in acute leukemia are not well-described. The California Cancer Registry, used to identify treated patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) diagnosed between 2009 and 2014, was linked with the statewide hospitalization database to determine cumulative incidences of UE DVT and subsequent VTE and bleeding after UE DVT diagnosis. Cox proportional hazards regression models were used to assess the association of UE DVT on the risk of subsequent pulmonary embolism (PE) or lower extremity deep vein thrombosis (LE DVT) and subsequent bleeding, and the impact of UE DVT on mortality. There were 5,072 patients identified: 3,252 had AML and 1,820 had ALL. Three- and 12-month cumulative incidences of UE DVT were 4.8% (95% confidence interval [CI]: 4.1-5.6) and 6.6% (95% CI: 5.8-7.5) for AML and 4.1% (95% CI: 3.2-5.1) and 5.9% (95% CI: 4.9-7.1) for ALL, respectively. Twelve-month cumulative incidences of subsequent VTE after an incident UE DVT diagnosis were 5.3% for AML and 12.2% for ALL. Twelve-month cumulative incidences of subsequent bleeding after an incident UE DVT diagnosis were 15.4% for AML and 21.1% for ALL. UE DVT was associated with an increased risk of subsequent bleeding for both AML (hazard ratio [HR]: 2.07; 95% CI: 1.60-2.68) and ALL (HR: 1.62; 95% CI: 1.02-2.57) but was not an independent risk factor for subsequent PE or LE DVT for either leukemia subtype. Isolated incident UE DVT was associated with increased leukemia-specific mortality for AML (HR: 1.42; 95% CI: 1.16-1.73) and ALL (HR: 1.80; 95% CI: 1.31-2.47). UE DVT is a relatively common complication among patients with AML and ALL and has a significant impact on bleeding and mortality. Further research is needed to determine appropriate therapy for this high-risk population." @default.
- W3096195771 created "2020-11-09" @default.
- W3096195771 creator A5000669662 @default.
- W3096195771 creator A5051663127 @default.
- W3096195771 creator A5054146743 @default.
- W3096195771 creator A5060558335 @default.
- W3096195771 creator A5091575846 @default.
- W3096195771 date "2020-10-01" @default.
- W3096195771 modified "2023-09-24" @default.
- W3096195771 title "Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality" @default.
- W3096195771 cites W1494928676 @default.
- W3096195771 cites W1519925643 @default.
- W3096195771 cites W1558704041 @default.
- W3096195771 cites W1963785346 @default.
- W3096195771 cites W1969176274 @default.
- W3096195771 cites W1970889259 @default.
- W3096195771 cites W1971211622 @default.
- W3096195771 cites W1979433036 @default.
- W3096195771 cites W2000755087 @default.
- W3096195771 cites W2007086823 @default.
- W3096195771 cites W2021414870 @default.
- W3096195771 cites W2021776778 @default.
- W3096195771 cites W2033150840 @default.
- W3096195771 cites W2034085555 @default.
- W3096195771 cites W2038981426 @default.
- W3096195771 cites W2045858611 @default.
- W3096195771 cites W2053817144 @default.
- W3096195771 cites W2055987519 @default.
- W3096195771 cites W2059152519 @default.
- W3096195771 cites W2060310935 @default.
- W3096195771 cites W2063853621 @default.
- W3096195771 cites W2073193043 @default.
- W3096195771 cites W2084350813 @default.
- W3096195771 cites W2093389482 @default.
- W3096195771 cites W2094997729 @default.
- W3096195771 cites W2107355614 @default.
- W3096195771 cites W2115107921 @default.
- W3096195771 cites W2115108310 @default.
- W3096195771 cites W2124601331 @default.
- W3096195771 cites W2127901874 @default.
- W3096195771 cites W2172181565 @default.
- W3096195771 cites W2179164822 @default.
- W3096195771 cites W2262426318 @default.
- W3096195771 cites W2273849032 @default.
- W3096195771 cites W2313284959 @default.
- W3096195771 cites W2332736166 @default.
- W3096195771 cites W2490019007 @default.
- W3096195771 cites W2606606817 @default.
- W3096195771 cites W2607302953 @default.
- W3096195771 cites W2618295227 @default.
- W3096195771 cites W2622667479 @default.
- W3096195771 cites W2782210394 @default.
- W3096195771 cites W2802196698 @default.
- W3096195771 cites W2802486532 @default.
- W3096195771 cites W2860427860 @default.
- W3096195771 cites W2921810724 @default.
- W3096195771 cites W2925232930 @default.
- W3096195771 cites W2948033319 @default.
- W3096195771 cites W2958488683 @default.
- W3096195771 cites W2993026013 @default.
- W3096195771 cites W3032368633 @default.
- W3096195771 cites W4246907525 @default.
- W3096195771 cites W4327766780 @default.
- W3096195771 cites W4376595850 @default.
- W3096195771 doi "https://doi.org/10.1055/s-0040-1718883" @default.
- W3096195771 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7593117" @default.
- W3096195771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33134806" @default.
- W3096195771 hasPublicationYear "2020" @default.
- W3096195771 type Work @default.
- W3096195771 sameAs 3096195771 @default.
- W3096195771 citedByCount "4" @default.
- W3096195771 countsByYear W30961957712021 @default.
- W3096195771 countsByYear W30961957712022 @default.
- W3096195771 countsByYear W30961957712023 @default.
- W3096195771 crossrefType "journal-article" @default.
- W3096195771 hasAuthorship W3096195771A5000669662 @default.
- W3096195771 hasAuthorship W3096195771A5051663127 @default.
- W3096195771 hasAuthorship W3096195771A5054146743 @default.
- W3096195771 hasAuthorship W3096195771A5060558335 @default.
- W3096195771 hasAuthorship W3096195771A5091575846 @default.
- W3096195771 hasBestOaLocation W30961957711 @default.
- W3096195771 hasConcept C120665830 @default.
- W3096195771 hasConcept C121332964 @default.
- W3096195771 hasConcept C126322002 @default.
- W3096195771 hasConcept C141071460 @default.
- W3096195771 hasConcept C207103383 @default.
- W3096195771 hasConcept C2776265017 @default.
- W3096195771 hasConcept C2778959117 @default.
- W3096195771 hasConcept C2780011451 @default.
- W3096195771 hasConcept C2780868729 @default.
- W3096195771 hasConcept C44249647 @default.
- W3096195771 hasConcept C50382708 @default.
- W3096195771 hasConcept C61511704 @default.
- W3096195771 hasConcept C71924100 @default.
- W3096195771 hasConcept C72563966 @default.
- W3096195771 hasConcept C88879693 @default.
- W3096195771 hasConceptScore W3096195771C120665830 @default.
- W3096195771 hasConceptScore W3096195771C121332964 @default.